FHIR Composition
subject (reference
US Core Patient Profile
or
Group)

Is the Pharmacist Consultation Note guidance specification intended to support veterinary medicine practice?
If not:
What is | are the use case(s) supporting inclusion of "Group" in pharmacist consultation in human medicine practice?
Suggest remove "Group" if there is no compelling use case(s) to support inclusion in human medicine practice